Recent publications

Timmerman, A., Rodenhuis, N., Crane-van Opstal, L. M. A., de Boer, A., Bongers, L., & Pasmooij, A. M. G. (2026). Factors influencing pharmaceutical companies’ decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands. Journal of Pharmaceutical Policy and Practice, 19(1), Article 2605391. https://doi.org/10.1080/20523211.2025.2605391

Tillemans, M. P. H., Giezen, T. J., Egberts, T. C. G., & J. Kalisvaart, K. (2026). The association between medication use and vitamin B12 deficiency in the elderly population: a cross- sectional study. BMC Geriatrics, 26(1), Article 294. https://doi.org/10.1186/s12877-026-07040-6

Kashmour, S., Kempen, T. G. H., Boussaboun, Y., & Gemmeke, M. (2026). Women's perspectives on acute cystitis care and the role of the community pharmacy: a qualitative study. SSM - Qualitative Research in Health, 9, Article 100727. https://doi.org/10.1016/j.ssmqr.2026.100727

Lasys, T. (2026). Assessing Impact of Pharmacovigilance Interventions in Europe: Methods and Applications. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/3352

Moslemzadeh, D., Souverein, P. C., Belitser, S. V., Heerdink, E. R., Klungel, O. H., & Abtahi, S. (2026). Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study. Pharmacoepidemiology and Drug Safety, 35(3), Article e70343. https://doi.org/10.1002/pds.70343

Kleine Schaars, K., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H. J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., Deneer, V. H. M., & van Westrhenen, R. (2026). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants. European Journal of Human Genetics, 34, 379-386. https://doi.org/10.1038/s41431-025-02008-3

Gemmeke, M., Jansen, M. C., Kempen, T. G. H., & Bouvy, M. L. (2026). Healthcare providers' perspectives on collaboration of care for acute cystitis in women and the role of the community pharmacy: A qualitative study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100694. https://doi.org/10.1016/j.rcsop.2025.100694

Falke, C., Karapinar-Carkit, F., Knol, W., Bouvy, M., Egberts, T., Kempen, T., Vervloet, M., & Heringa, M. (2026). Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100692. https://doi.org/10.1016/j.rcsop.2025.100692

Mohmaed Ali, M. I., van der Heijden, L. T., Tibben, M., Rosing, H., Kalicharan, R., Ruiter, G., Beijnen, J. H., Huisman-siebinga, H., Huitema, A. D. R., & Steeghs, N. (2026). Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib. Clinical Pharmacology & Therapeutics, 119(3), 713-720. https://doi.org/10.1002/cpt.70141

Rosenberg, N., Hollak, C. E. M., Haverhoek, V. A., Stoyanova-Beninska, V., Pasmooij, A. M. G., & de Visser, S. J. (2026). Tracing the path of non-industry-driven medicine development for rare diseases through regulatory interactions at the European Medicines Agency. Drug Discovery Today, Article 104631. https://doi.org/10.1016/j.drudis.2026.104631

Coppes, T., Koster, E. S., Philbert, D., van Gelder, T., & Bouvy, M. L. (2026). ESCP best practice: development, implementation and evaluation of sick day guidance in primary care in the Netherlands. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-026-02097-0

Hazen, A., Kempen, T., Leendertse, A., Bouvy, M., van Dijk, L., & Zwart, D. (2026). Patients' Perspectives on the Role of General Practice-Based Pharmacists: A Focus Group Study. Patient Preference and Adherence, 20, Article 565194. https://doi.org/10.2147/PPA.S565194

Riera-Arnau, J., Paoletti, O., Gini, R., Thurin, N. H., Souverein, P. C., Abtahi, S., Durán, C., Pajouheshnia, R., & Roberto, G. (2026). Standardisation of terminology, calculation and reporting for assigning exposure duration to drug utilisation records from healthcare data sources: the CreateDoT framework. medRxiv. https://doi.org/10.64898/2026.02.18.26346576

Beravs-Bervar, K., Goettsch, W., Gutierrez-Ibarluzea, I., Skali, A., Rűther, A., Lipska, I., & Turk, E. (2026). Strengthening Health Technology Assessment (HTA) in the European Union: Insights from Slovenia's Implementation Journey. International Journal of Technology Assessment in Health Care. Advance online publication. https://doi.org/10.1017/S0266462325103383

Grupstra, R. J., Starokozhko, V., Bakker, E., Pasmooij, A. M. G., & Mol, P. G. M. (2026). More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations. Clinical Pharmacology and Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.70229

Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., van Steenbergen, L. N., Dahan, A., Rosendaal, F. R., & Gademan, M. G. J. (2026). Association of benzodiazepine and opioid use with hip fracture treated with arthroplasty: a nationwide case-control study. BMC Geriatrics. Advance online publication. https://doi.org/10.1186/s12877-025-06803-x

Petro, E., van den Ham, H. A., Mantel-Teeuwisse, A. K., Martopullo, H., Joosse, I. R., & Suleman, F. (2026). Access to pediatric medicines in Albania: A qualitative study of family doctors’ perceptions. PLOS Global Public Health, 6(2), Article e0005861. https://doi.org/10.1371/journal.pgph.0005861

van de Burgt, B. W. M., van Dijck, L. F. C., Dullemond, B., Jessurun, N. T., van Seyen, M., van Marum, R. J., van Wensen, R. J. A., Liu, W. Y., van der Linden, C. M. J., Grouls, R. J. E., Bouwman, R. A., Korsten, E. H. M., & Egberts, T. C. G. (2026). Portability of a text mining algorithm for detecting adverse drug reactions in electronic health records across diverse patient groups in two Dutch hospitals. PLOS Digital Health, 5(2), Article e0001230. https://doi.org/10.1371/journal.pdig.0001230

Galli, M., Pereira, N. L., Lennon, R. J., van den Broek, W. W. A., Claassens, D. M. F., Bergmeijer, T. O., Rosenberg, Y., Fazzini, L., Deneer, V. H. M., Murad, M. H., Farkouh, M. E., Rihal, C., ten Berg, J., & Angiolillo, D. J. (2026). Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC: Cardiovascular Interventions. Advance online publication. https://doi.org/10.1016/j.jcin.2025.11.029

Bouwman, L., Leufkens, H., Sepodes, B., & Torre, C. (2026). Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023. PloS one, 21(2), Article e0342698. https://doi.org/10.1371/journal.pone.0342698

Lasys, T., Essink, S. C. M., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Zomerdijk, I. M., Groenwold, R. H. H., Bruin, M. L. D., & Gardarsdottir, H. (2026). Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis. European Journal of Clinical Pharmacology, 82(3), Article 68. https://doi.org/10.1007/s00228-025-03992-7

Eskola, S. M., Gigov, A., Leufkens, H. G. M., Bate, A., De Bruin, M. L., & Gardarsdottir, H. (2026). Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70471

Baas, G., Heringa, M., Verdoorn, S., Kwint, H.-F., Badawy, E., Gussekloo, J., & Bouvy, M. (2026). A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed-Methods Feasibility Study. Basic & Clinical Pharmacology & Toxicology, 138(2), Article e70184. https://doi.org/10.1111/bcpt.70184

van Dijk, E. J., Smeenk, M. M., Bensch, F., Sadowksa, A. M., Verschueren, M. V., Verhaert, M., Llobell, A., Suzuki, Y., Liew, D. F. L., Takeji, A., Maria, A. T. J., Peters, B. J. M., Garcia Morillo, J. S., Chatzidionysiou, K., Lidar, M., van der Hout, E. C., Aspeslagh, S., Herder, G. J. M., van de Garde, E. M. W., ... Verheijden, R. J. (2026). Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer. ESMO Open, 11(2), Article 106052. https://doi.org/10.1016/j.esmoop.2025.106052

Kaló, Z., Petrova, G., Németh, B., Bonča, P. D., Delnoij, D., Bennett, A., Tachkov, K., Zhang, Y., Kreif, N., Knies, S., Lipska, I., Tesar, T., Mitkova, Z., Ponten, J., Viberg, A., Paveliu, M. S., Piniazkho, O., Turcu-Stiolica, A., Doležal, T., ... Manca, A. (2026). Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. Health Science Reports, 9(2), Article e71534. https://doi.org/10.1002/hsr2.71534

Kempen, T. G. H., Fayzi, Z., & Mertens, J. F. (2026). Competencies needed for pharmacist prescribing: A qualitative study of competency frameworks to identify gaps in Dutch pharmacy education. Currents in Pharmacy Teaching and Learning, 18(5), Article 102589. Advance online publication. https://doi.org/10.1016/j.cptl.2026.102589

Delnoij, D. M. J., Dawoud, D. M., Elvidge, J., Kaló, Z., Knies, S., Németh, B., & Goettsch, W. (2026). Innovating HTA: a call for capacity building and standardization. International Journal of Technology Assessment in Health Care, 42(1), Article e8. https://doi.org/10.1017/S0266462326103456

de Booij, G., Besselsen, S., Philbert, D., Bouvy, M., Haeck, I. M., van Tuyll van Serooskerken, A.-M., & Gemmeke, M. (2026). Waardering voor nieuwe uitlegkaart, gids en smeerplan over eczeem: Kleinschalig onderzoek onder patiënten en zorgverleners over informatiematerialen. Pharmaceutisch Weekblad, 161(4), 20-22. https://www.pw.nl/achtergrond/waardering-voor-nieuwe-uitlegkaart-gids-en-smeerplan-over-eczeem

Falke, C. M., Koolen, M. F. J., Timmer, S. L., Karapinar-Çarkit, F., Bouvy, M. L., Egberts, A. C. G., & Knol, W. (2026). Perspectives of Older Patients on the Complexity of Medication Use. Journal of the American Geriatrics Society. Advance online publication. https://doi.org/10.1111/jgs.70311

Annema, P. A., Venrooij, L. M. W. N., Bouvy, M. L., van Marum, R. J., & Derijks, H. J. (2026). Patient perspectives on drug recalls in the Netherlands: a qualitative study. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-025-02082-z

Leopold, C., Huisman, A. H., Vlaar, K. J. G. M., Bloemendal, H. J., & Barjesteh van Waalwijk van Doorn-Khosrovani, S. (2026). Stakeholders’ experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the Netherlands. Acta Oncologica, 65, 22-31. https://doi.org/10.2340/1651-226X.2026.45000

Harding, E., de Fouw, C., Bouvy, M. L., van Woerkom, M., & van der Ende, M. Y. (2026). Therapietrouw. Nederlands Tijdschrift voor Geneeskunde, 170, Article D8823. https://www.ntvg.nl/artikelen/therapietrouw-0

CONSIGN Collaboration Group, de Bruin, O., Maisonneuve, E., Hurley, E., Nordeng, H. M. E., Bérard, A., Sheehy, O., Kaul, P., Shinde, M. U., Cosgrove, A., Lyons, J. G., Messenger-Jones, E., Kempner, M. E., Toh, S., Hua, W., Hernández-Muñoz, J. J., Sahin, L., Cesta, C. E., Hägg, D., ... Sturkenboom, M. C. J. M. (2026). Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North America. Pharmacoepidemiology and Drug Safety, 35(1), Article e70303. https://doi.org/10.1002/pds.70303

Kruithof, P. D., Souverein, P. C., Driessen, J. H. M., Hendriks, L. E. L., Croes, S., & van Geel, R. M. J. M. (2026). Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry Data. Pharmacoepidemiology and Drug Safety, 35(1), Article e70299. https://doi.org/10.1002/pds.70299

van der Zee, I. T., Hoek, J. M., Hoekman, J., & De Bruin, M. L. (2026). Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literature. Drug Discovery Today, 31(1), Article 104597. https://doi.org/10.1016/j.drudis.2026.104597

Lambert, M., Mmassy, J., Kabissi, S., Benizeth, C., Baltazary, G., Maganda, B. A., & Taxis, K. (2026). Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting. International Health, 18(1), 1-4. https://doi.org/10.1093/inthealth/ihaf079

Adhien, P. (2026). NEDERLAND MOET ZICH AANSLUITEN BIJ EUROPA INZAKE BEHANDELING OBESITAS:HANTEREN VAN VERSCHILLENDE RICHTLIJNEN IS VERWARREND EN ACHTERHAALD. Pharmaceutisch Weekblad, 161(5), 32-33.

Rijke, N., Yamout, B. I., Saylor, D., Nonino, F., Filippini, G., Piggott, T., Laurson-Doube, J., Amato, L., Banerjee, T. K., Costello, K., Giovane, C. D., De Stefano, N., Abkari, N. E., Giovannoni, G., Hartung, H. P., Helme, A., Mantel-Teeuwisse, A., Prato Chichiraldi, A., Ali Sahraian, M., ... Schünemann, H. (2026). Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings. Multiple Sclerosis and Related Disorders, 105, Article 106878. https://doi.org/10.1016/j.msard.2025.106878

Coenen, M. J. H., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & van Schaik, R. H. N. (2026). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines. European Journal of Human Genetics, 34(1), 152–160. https://doi.org/10.1038/s41431-025-01986-8

Cooijmans, S., Engelen, E. M. C., Wuyts, S. C. M., Kramers, C., van Agtmael, M. A., van den Bemt, P. M. L. A., Bouvy, M. L., Amouch, H., Autar, R. S., Benoist, G. E., van Berlo-van de Laar, I. R. F., Derijks-Engwegen, J. Y. M. N., van den Elsen, G., Engelaer, F. M., Gombert-Handoko, K. B., Jansen, D. R. M., Kerskes, M. H. M., Kruik-Kollöffel, W. J., Kuijvenhoven, M. A., ... Knol, W. (2025). Less Is More: Optimized pharmacotherapy with improved coNtinuity of CarE in hospitaLized oLder peOple (LIMONCELLO): study protocol of a cluster randomized controlled trial. BMC Geriatrics, 25(1), Article 1034. https://doi.org/10.1186/s12877-025-06533-0

Van Gelder, T. G., Vergoossen, D., Zonnenberg, I. A., Lalmohamed, A., Koole-Oostveen, M. I., van Reij, E. M. L., van Loon, A., & Egberts, T. C. G. (2025). Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit. European Journal of Hospital Pharmacy, 33(1), 73-79. https://doi.org/10.1136/ejhpharm-2024-004300

Lambert, M., Aljadeeah, S., Nasir, N., Sila, F., Lopes, L., & Llor, C. (2025). Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices. The Lancet Primary Care, Article 100084. Advance online publication. https://doi.org/10.1016/j.lanprc.2025.100084

CONSIGN Collaboration Group, de Bruin, O., Maisonneuve, E., Hurley, E., Nordeng, H. M. E., Bérard, A., Sheehy, O., Kaul, P., Shinde, M. U., Cosgrove, A., Lyons, J. G., Messenger-Jones, E., Kempner, M. E., Toh, S., Hua, W., Hernández-Muñoz, J. J., Sahin, L., Cesta, C. E., Hägg, D., ... Sturkenboom, M. C. J. M. (2025). Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North America. International Journal of Gynecology and Obstetrics. Advance online publication. https://doi.org/10.1002/ijgo.70694

Gort, J., van Hattem, C. C., Logman, F., Frederix, G. W. J., Hooft, L., Bloem, L. T., & Ten Ham, R. M. T. (2025). Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands. Regenerative Medicine. Advance online publication. https://doi.org/10.1080/17460751.2025.2594314

Verschueren, M. V., Verschueren, D. V., van de Garde, E. M. W., & Bloem, L. T. (2025). A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients. CPT: Pharmacometrics and Systems Pharmacology, 14(12), 2006-2013. https://doi.org/10.1002/psp4.70075

Bognar, T. T., Garcia, M. M., Lalmohamed, A. A., Gungor, T. T., Hauri-Hohl, M. M., Prockop, S. S., Oram, L. L., Pai, S.-Y. S., Brooks, J. J., Savic, R. M. R., Dvorak, C. C. C., Long-Boyle, J. R. J., Krajinovic, M. M., Bittencourt, H. H., Teyssier, A. C. A.-C., Theoret, Y. Y., Martinez, C. C., Egberts, A. C. G. T., Morales, E. E., ... Bartelink, I. H. I. (2025). Association of Busulfan Exposure and Outcomes After Hematopoietic Cell Transplantation for Patients With an Inborn Error of Immunity. Therapeutic Drug Monitoring, 47(6).

Petro, E., Martopullo, T., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). 'Challenges in pediatric medicine access in Albania: insights from community Pharmacists'. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2521425. https://doi.org/10.1080/20523211.2025.2521425

Su, L., Chen, L., Betigeri, S., Dreyer, N., Gardarsdottir, H., Hendricks-Sturrup, R., & Burcu, M. (2025). Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real-World Data Utilization. Clinical Pharmacology and Therapeutics, 118(6), 1350-1365. https://doi.org/10.1002/cpt.70033

Arnamo, A. H., Pluim, D., Huitema, A. D. R., Jacobs, B. A. W., Beijnen, J. H., & Nuijen, B. (2025). Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials. Journal of Oncology Pharmacy Practice, 31(8), 1199-1209. https://doi.org/10.1177/10781552241279018

Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(12), 1873-1874. https://doi.org/10.1007/s00228-025-03917-4

Lambert, M., van Dijk, L., Benko, R., Llor, C., Lykkegaard, J., Mantel-Teeuwisse, A. K., Pont, L., & Taxis, K. (2025). The role of the community pharmacist in antibiotic use – a commentary on current status and future perspectives. Exploratory Research in Clinical and Social Pharmacy, 20, Article 100652. https://doi.org/10.1016/j.rcsop.2025.100652

Petro, E., Joosse, I. R., Siebers, A. C. M., Martopullo, T., Hart, R. P. M., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). Time and cost involved in measuring access to medicines: the case of Albania. BMC Research Notes, 18(1), Article 104. https://doi.org/10.1186/s13104-025-07168-5

Zhang, X. Y. C., Scott, E. N., Maagdenberg, H., Man, A., Li, K. H., Rassekh, S. R., Carleton, B. C., Ross, C. J. D., Wasserman, W. W., & Loucks, C. M. (2025). Pathway-Informed Machine Learning Identifies Genetic Predictors of High-Dose Methotrexate-Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia. Clinical Pharmacology & Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.70135

Joosse, I. R., Mantel-Teeuwisse, A., Van den Ham, H. A., & Cantarero Arevalo, L. (2025). Availability of essential medicines for non-communicable diseases: a scoping review of challenges and opportunities. BMJ Global Health, 10(11), Article e019634. https://doi.org/10.1136/bmjgh-2025-019634

Van Brug, H. E., Nelissen, R. G. H. H., Rosendaal, F. R., Van Steenbergen, L. N., Bouvy, M. L., Dahan, A., & Gademan, M. (2025). Association of preoperative chronic opioid use with 1-year revision rate, mortality, and patient-reported outcomes after primary hip and knee arthroplasty: age, sex and BMI matter - a Dutch register-based study. Acta Orthopaedica, 96, 857-866. https://doi.org/10.2340/17453674.2025.44597

Versteeg, J.-W., Stam, N., Mantel-Teeuwisse, A. K., Timmers, L., Goettsch, W., & Leopold, C. (2025). Coverage With Evidence Development For Medicines with Insufficient Evidence Of Clinical Benefit: Experience From The Netherlands. International Journal of Technology Assessment in Health Care, 41(1), Article e83. https://doi.org/10.1017/S0266462325103267

van Vliet, E. D., Buhl, C., Jacobsen, R., Andersen, A., Almarsdóttir, A. B., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Kos, M., Čebron Lipovec, N., Ribeiro-Vaz, I., Silva, A. M., Ferreira, P., Poplavska, E., Abtahi, S., Hegger, I., & Leonardo Alves, T. (2025). Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2576620. https://doi.org/10.1080/20523211.2025.2576620

Rosenberg, N., Post, H. C., Schutte, T., de Visser, S. J., Bartelink, I., Pasmooij, A. M. G., van Laarhoven, H. W. M., & Hollak, C. E. M. (2025). Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries. ESMO Open, 10(11), Article 105855. https://doi.org/10.1016/j.esmoop.2025.105855

Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2025). Barriers and facilitators for effective sick day guidance implementation. Journal of Nephrology, 38(8), 2463-2467. https://doi.org/10.1007/s40620-025-02396-1

Zuidgeest, M. G. P., Heath, M., Lagerwaard, B., van Weelij, D. R., Rutgrink, L., Hanke, S., Vedenkannas, T., Kosonen, T., Collamati, S., Fons-Martinez, J., Veen, D., Gardarsdottir, H., Mackenzie, I. S., Dupont, S., Grobbee, D. E., & consortium, T. (2025). Bringing Trial Activities to Participants-The Trials@Home RADIAL Proof-of-Concept Trial Investigating Decentralization of Trials. Clinical Pharmacology & Therapeutics, 118(5), 1037-1045. https://doi.org/10.1002/cpt.70025

Their, A., Elens, R., Baltira, C., Szewczyk, A., Rozing, K., Beijnen, J., De Gooijer, M., & Van Tellingen, O. (2025). Development of a multi-target drug combination targeting three major proliferation pathways in glioblastoma. Neuro-Oncology, 27(Supplement_5), v367-v367. https://doi.org/10.1093/neuonc/noaf201.1451

Morales, D. R., & Gardarsdottir, H. (2025). From Evidence to Impact: Closing the Loop in Pharmacovigilance With Real-World Data. Pharmacoepidemiology and Drug Safety, 34(11), Article e70244. https://doi.org/10.1002/pds.70244

Castillo-Cano, B., Riefolo, F., Villalobos, F., Martín-Pérez, M., Messina, D., Elbers, R., Brink-Kwakkel, D., Bissacco, C. A., Segundo, E., Saiz, L. C., Leache, L., Barbieri, E., Vaz, T., Gini, R., Klungel, O., & Martín-Merino, E. (2025). Impact and Effectiveness of COVID-19 mRNA Vaccination Against COVID-19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain. Pharmacoepidemiology and Drug Safety, 34(11), Article e70239. https://doi.org/10.1002/pds.70239

Ljungdahl, N., Kempen, T., & Sporrong, S. K. (2025). Person-centred care in practice: Observational study of pharmacist and healthcare team encounters with patients with chronic pain in primary care. Research in Social and Administrative Pharmacy, 21(11). https://doi.org/10.1016/j.sapharm.2025.06.077

Kalkhoran, H. A., Verschueren, M. V., Peters, B. J. M., van de Garde, E. M. W., Smit, E. F., Bohringer, S., Cohen, D., Gulikers, J. L., Codrington, H., Guchelaar, H.-J., Visser, L. E., & Zwaveling, J. (2025). Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression? Clinical Lung Cancer, 26(7), e599-e608.e2. https://doi.org/10.1016/j.cllc.2025.07.009

IMI Trials@Home Consortium, Gardarsdottir, H., Traore, H., Huntley, K., Mistry, D., de Jong, A. J., Legathe, A., de Smedt, T., Askin, S., Heath, M., Corriol-Rohou, S., Lagerwaard, B., & Zuidgeest, M. G. P. (2025). Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on Decentralization. Clinical Pharmacology and Therapeutics, 118(5), 1046-1056. https://doi.org/10.1002/cpt.70078

Kurz, X., Cohet, C., Perez-Gutthann, S., Rao, S., & Gardarsdottir, H. (2025). Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiology and Drug Safety, 34(11), Article e70263. https://doi.org/10.1002/pds.70263

Leung, M. W. Y., van de Garde, E. M. W., Uitdehaag, B. M. J., Souverein, P. C., Klungel, O. H., & Bazelier, M. T. (2025). The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study. Pharmacoepidemiology and Drug Safety, 34(11), Article e70260. https://doi.org/10.1002/pds.70260

Callenbach, M. H. E., van den Berg, S., Hulsbosch, A., Hollak, C. E. M., Leopold, C., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2025). Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix. Orphanet Journal of Rare Diseases, 20(1), Article 540. https://doi.org/10.1186/s13023-025-04020-8

Zafiropoulos, N., Pignatti, F., Kouroumalis, A., Guizzaro, L., Karres, D., Demolis, P., Tenhunen, O., Janssens, R., Taams, A., Bloem, L. T., Koenig, F., & Posch, M. (2025). A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications. Frontiers in Medicine, 12, Article 1589578. https://doi.org/10.3389/fmed.2025.1589578

Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., Rosendaal, F. L., Van Steenbergen, L. N., Dahan, A., & Gademan, M. G. J. (2025). 10-year trends in benzodiazepine, opioid, and concurrent use in hip and knee arthroplasty: a nationwide cohort study from the Netherlands. Acta Orthopaedica, 96, 771-779. https://doi.org/10.2340/17453674.2025.44755

on behalf of the COSEB Consortium, Korte, E. W. H., van den Akker, P. C., Kiritsi, D., Kottner, J., Pasmooij, A. M. G., Prinsen, C. A. C., Wally, V., Welponer, T., Spuls, P. I., Laimer, M., & Bolling, M. C. (2025). Core outcome domain sets for clinical trials in epidermolysis bullosa — a COSEB protocol to achieve consensus on “what” to measure. Trials, 26(1), Article 399. https://doi.org/10.1186/s13063-025-09052-w

Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Groenwold, R. H. H., & Gardarsdottir, H. (2025). Impact of diclofenac risk minimization measures addressing cardiovascular risk on analgesic use in musculoskeletal disorders. British Journal of Clinical Pharmacology, 91(10), 2998-3008. https://doi.org/10.1002/bcp.70142

Eskola, S. M., Sykes, N., Atzor, S., Garcia-Palacios, G., Dzambazoska, J., Spooner, Á., Rex, M., Neil, B., Chlebus, M., De Bruin, M. L., Gardarsdottir, H., & Neez, E. (2025). Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revision. Drug Discovery Today, 30(10), Article 104468. https://doi.org/10.1016/j.drudis.2025.104468

Sadreghaemy, M., Philbert, D., Heerdink, E. R., Bouvy, M. L., Egberts, T. C. G., & Bloem, L. T. (2025). Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment. British Journal of Clinical Pharmacology, 91(10), 2771-2781. https://doi.org/10.1002/bcp.70244

Ubiquitous Pharmacogenomics Consortium, Guchelaar, H.-J., van der Wouden, C. H., Manson, L. E. N., Abdullah-Koolmees, H., Blagec, K., Blagus, T., Böhringer, S., Cecchin, E., Cheung, K.-C., Deneer, V. H. M., Jonsson, S., Joefield-Roka, C., Just, K. S., Karlsson, M. O., Konta, L., Koopmann, R., Kriek, M., Lehr, T., ... Swen, J. J. (2025). Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study. Clinical Pharmacology and Therapeutics, 118(4), 803-812. https://doi.org/10.1002/cpt.3749

Werkman, N. C. C., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., Bosma, H., Schram, M. T., van Greevenbroek, M. M. J., Wesselius, A., Stehouwer, C. D. A., Driessen, J. H. M., & Garcia-Sáez, G. (2025). Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study. Diabetes, Obesity & Metabolism, 27(10), 5524-5537. https://doi.org/10.1111/dom.16598

van der Bij, R., & Pieters, T. (2025). RELATIE TUSSEN MENSEN NATUUR IS ALTIJD VEELZIJDIG GEWEEST. Pharmaceutisch Weekblad, 160(41-42), 12-13 and 15.

Bruin, M. A. C., Lucas, L., Beijnen, J. H., Huitema, A. D. R., & Rosing, H. (2025). Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) Phosphate: A Short Communication. Therapeutic Drug Monitoring, 47(5), 686-690. https://doi.org/10.1097/FTD.0000000000001339

Juhasova, Z., Karapinar-Carkit, F., & Weir, D. L. (2025). The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study. British Journal of Clinical Pharmacology, 91(10), 2910-2918. https://doi.org/10.1002/bcp.70116

Ljungdahl, N., Kälvemark-Sporrong, S., Tranberg, A., & Kempen, T. (2025). Pharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-025-02006-x

Putnina, Z., Ernst, J. D., van der Tuin, I., Dirks, S., & Pieters, T. (2025). Evaluating the ArtBot Guide: A Toolkit for Enhancing Engagement with Digitized Museum Collections. Digital Society, 4, Article 66. https://doi.org/10.1007/s44206-025-00222-6

Ambrosio, L., Kamerling, C., de Jong, C. D. C., Herder, J. G. J. M., Egberts, T. A. C. G., & Deneer, V. V. H. M. (2025). Associatie tussen genetische varianten an oesofagitis bij NSCLC-patiënten behandeld met platinahoudend chemotherapie en radiotherapie: een prospectieve observationele studie. Pharmaceutisch Weekblad, 160(38), 19-24. https://www.knmp.nl/resolveuid/dac4022ca9e645a4ac285f4ed3f97d01

Kashmour, S., Kempen, T., Boussaboun, Y., Bouvy, M., & Gemmeke, M. (2025). Blaasontstekingszorg in apotheek: Vrouwen stellen voorwaarden. Pharmaceutisch Weekblad, 160(36), 18-20.

Costa, E., van den Ham, H. A., & Leufkens, H. G. M. (2025). Challenges and opportunities of adding CFTR modulators for cystic fibrosis to the WHO essential medicines list. Journal of Cystic Fibrosis, 24(5), 920-922. https://doi.org/10.1016/j.jcf.2025.06.006

Mahomedradja, R. F., Bognàr, T., van Schie, K. E., Kuipers, I. T., de Witte, M. A., Kuball, J. H. E., Nur, E., Wilhelm, B. J., Heerma van Voss, M. R., Franken, L., Lalmohamed, A., Swart, E. N. L., de Leeuw, D. C., & Bartelink, I. H. (2025). Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations. Clinical Pharmacology and Therapeutics, 118(3), 723-734. https://doi.org/10.1002/cpt.3748

Willemsen, A., Rutten-van Mölken, M., Al Dulaimi, R., Schelleman, H., Goettsch, W., & Timmers, L. (2025). Preparing for the EU HTA Regulation: Insights from the Dutch Perspective. Journal of market access & health policy, 13(3), 1-19. Article 35. https://doi.org/10.3390/jmahp13030035

Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study. Drug Safety, 48(9), 1005-1022. https://doi.org/10.1007/s40264-025-01550-9

van Geloven, N., Keogh, R. H., van Amsterdam, W., Cinà, G., Krijthe, J. H., Peek, N., Luijken, K., Magliacane, S., Morzywołek, P., van Ommen, T., Putter, H., Sperrin, M., Wang, J., Weir, D. L., & Didelez, V. (2025). The Risks of Risk Assessment: Causal Blind Spots When Using Prediction Models for Treatment Decisions. Annals of Internal Medicine, 178(9), 1326-1333. https://doi.org/10.7326/ANNALS-24-00279

Molenaar, P., Weir, D., Arnoldus, E. P. J., Beenakker, M., van den Bos, R., Bouma, P., van Eijk, J., Feenstra, C., van Geel, B., Heersema, T., Hoitsma, E., Horvath, K., Killestein, J., Kragt, J., van Munster, C., Snoeijen, A., Wokke, B., Goettsch, W., Strijbis, E., ... Brigit, D. J. (2025). Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis. Multiple Sclerosis Journal, 31(S3), 359-360.

Coppes, T., Prins, H., van Amerongen, K. A., van Gelder, T., Koster, E. S., & Bouvy, M. L. (2025). Using simulated patient methodology to assess sick day guidance in community pharmacy: The case of an elderly patient with diabetes. Exploratory Research in Clinical and Social Pharmacy, 19, Article 100623. https://doi.org/10.1016/j.rcsop.2025.100623

Eroglu, T. E., Coronel, R., & Souverein, P. C. (2025). Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink. Open Heart, 12(2), Article e003254. https://doi.org/10.1136/openhrt-2025-003254

Jansen, M., Gemmeke, M., Bouvy, M., & Kempen, T. (2025). Nog aarzeling bij blaasontstekingservice vanuit de apotheek: Relatieve voordeel van taakverschuiving naar apotheek onvoldoende duidelijk . Pharmaceutisch Weekblad, 160(33-34). https://www.pw.nl/achtergrond/2025/nog-aarzeling-bij-blaasontstekingservice-vanuit-de-apotheek

Schouten, W. M., Van Bocxlaer, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., Kratz, J. M., Mowbray, C. E., & Dorlo, T. P. C. (2025). Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1262, Article 124652. https://doi.org/10.1016/j.jchromb.2025.124652

Lambert, M., Veldkamp, R., Weesie, Y., Lambooij, A., Cals, J. W. L., Taxis, K., van Dijk, L., & Hek, K. (2025). Adherence to antibiotic prescribing guidelines in Dutch primary care: an analysis of national prescription data on ear and respiratory tract symptoms and conditions among 384 general practices. Family Practice, 42(4), 1-8. Article cmaf031. https://doi.org/10.1093/fampra/cmaf031

Jacobs, T. G., Ooms, G. I., Mantel-Teeuwisse, A. K., & Suleman, F. (2025). Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out Monitoring. Pediatric Infectious Disease Journal, 44(8), 785-786. https://doi.org/10.1097/INF.0000000000004814

Lambert, M., Benko, R., Lykkegaard, J., Søndergaard, J., Olsen, J., Garcia-Sangenis, A., Anastasaki, M., Lionis, C., Hansen, M. P., Lundgren, P. T., Bruno, P., Raynal, F., Vallejo-Torres, L., Bjerrum, L., Jaruseviciene, L., Radzeviciene, R., Kowalczyk, A., Llor, C., & Taxis, K. (2025). Community pharmacists' role in optimising antibiotic use: The HAPPY PATIENT project to improve dispensing practices in five EU countries. Research in Social and Administrative Pharmacy, 21(8), 597-607. https://doi.org/10.1016/j.sapharm.2025.03.064

de Jong, A. J., Gardarsdottir, H., Santa-Ana-Tellez, Y., de Boer, A., & Zuidgeest, M. G. (2025). Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials Regulation. Clinical Trials, 22(4), 494-500. https://doi.org/10.1177/17407745241309293

Chen, M., Kuzyakov, Y., Zhou, J., Zamanian, K., Wang, S., Abdalla, K., Wang, J., Li, X., Li, H., Zhang, H., Mganga, K. Z., Li, Y., & Blagodatskaya, E. (2025). High soil salinity reduces straw decomposition but primes soil organic carbon loss. Soil Biology and Biochemistry, 207, 1-11. Article 109835. https://doi.org/10.1016/j.soilbio.2025.109835

Egberts, T., van Puijenbroek, E., & Leufkens, B. (2025). Obituary Ronald Meyboom: A Professional Life Devoted to Pharmacovigilance. Drug Safety, 48(8), 953-954. https://doi.org/10.1007/s40264-025-01577-y

Bartelink, I. H., Lalmohamed, A., Bognar, T., Nur, E., & Boelens, J. J. (2025). Optimizing Allogeneic Hematopoietic Cell Transplantation Outcomes Through Busulfan PK/PD. Transplantation and Cellular Therapy, 31(8), 477-479. https://doi.org/10.1016/j.jtct.2025.07.008

Rijmers, J., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2025). Resistance mutations and the blood-brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer. Acta Pharmaceutica Sinica B, 15(8), 3833-3851. https://doi.org/10.1016/j.apsb.2025.06.002

Narsai, K., Leufkens, H. G. M., Brinkhuis, F., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2025). Transitioning to regulatory harmonisation for medicines: a comparison between Africa and Europe. Drug Discovery Today, 30(8), Article 104416. https://doi.org/10.1016/j.drudis.2025.104416

Schouten, WM., van Bocxlaer, K., Rosing, H., Huitema, AD. R., Beijnen, JH., Kratz, JM., Mowbray, CE., & Dorlo, TP. C. (2025). Validated LC-MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI-0690 in Preclinical Target Site PK/PD Studies. Biomedical Chromatography, 39(8), 1-13. Article e70158. https://doi.org/10.1002/bmc.70158

Vallejo-Yagüe, E., de Vries, S. T., La Parra-Casado, D., Gardarsdottir, H., Faquetti, M. L., van Valkengoed, I., Aubrun, E., Douros, A., Guedes, S., Martinez-De La Torre, A., Wested, J., Ochi, T., Schumacher Dimech, A. M., Clair, C., Mehta, I., Ida, F., Soriano Gabarró, M., Korzh, O., Martínez-González, M., ... Nordeng, H. (2025). Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)-A Framework of Diversity and Fairness in Pharmacoepidemiologic Research. Pharmacoepidemiology and Drug Safety, 34(7), Article e70175. https://doi.org/10.1002/pds.70175

Barbier, L., Moscariello, P., Leufkens, H. G., Herold, R., & Pasmooij, A. M. G. (2025). A new European platform for advancing regulatory science research. Nature Reviews Drug Discovery, 24(7), 485-486. https://doi.org/10.1038/d41573-025-00024-y

Hogervorst, M. A., Vreman, R. A., Oduol, T. A., Mantel-Teeuwisse, A. K., Goettsch, W. G., & Kesselheim, A. S. (2025). Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis. Clinical Pharmacology and Therapeutics, 118(1), 95-105. https://doi.org/10.1002/cpt.3628

Maisonneuve, E., De Bruin, O., Favre, G., Oakley, E., Kim, J. Y. H., Farooq, F., Al-Fadel, N., Almutairi, A., Del Mar Gil, M., Fernandez Buhigas, I., Visentin, S., Cosmi, E., Surita, F., Souza, R. T., Cecatti, J. G., Costa, M. L., Sanin-Blair, J., Tolosa, J. E., Hadar, E., ... Sturkenboom, M. C. J. M. (2025). How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries. Pharmacoepidemiology and Drug Safety, 34(7), Article e70180. https://doi.org/10.1002/pds.70180

Engelen, E. M. C., Knol, W., Wuyts, S. C. M., Theunissen, D. A., Vondeling, A. M., Cooijmans, S., van Herwaarden, N., Kramers, C., van den Bemt, P. M. L. A., van Agtmael, M. A., & Bouvy, M. L. (2025). Older patients' experiences and needs regarding pharmacotherapeutic care in-hospital and after discharge. Patient Education and Counseling, 136, Article 108754. https://doi.org/10.1016/j.pec.2025.108754

van Rijt-Weetink, Y. R. J., van Gendt, J., Egberts, T. C. G., van Hunsel, F. P. A. M., Lewis, D. J., Yates, L. M., Winterfeld, U., & van Puijenbroek, E. P. (2025). Quality of Clinical Information in Pregnancy Pharmacovigilance Data Sources-A Contribution of the ConcePTION Project. Pharmacoepidemiology and Drug Safety, 34(7), Article e70182. https://doi.org/10.1002/pds.70182

Meije, R. I., Selvanayagam, T., Philbert, D., Bouvy, M. L., Haeck, I. M., Dreesens, D., van Tuyll-van Serooskerken, A.-M., & Gemmeke, M. (2025). New educational materials about atopic dermatitis for primary care: pharmacy staff's and patients' perspectives. Journal of Public Health . Advance online publication. https://doi.org/10.1007/s10389-025-02535-9

Estapé Senti, M., Ceccaldi, A., Luciani, M., Saber, N., Schurmann, P. J. L., Geerlings, M. W., Holig, P., de Beer, J., Hannus, M., Campbell, F., Winter, M., van Hoeve, W., Westerik, M., Dorst-Mooiman, K. D., Dekker, J., Fuchs, S., Wolbers, F., Segers, T., IJzerman, M., ... Schiffelers, R. M. (2025). NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines. Frontiers in Science, 3, Article 1458636. https://doi.org/10.3389/fsci.2025.1458636

Knikman, J. E., de With, M., Heersche, N., Lopez-Yurda, M., Baars, A., Creemers, G. J., Droogendijk, H. J., Fiets, E., Imholz, A. L. T., Iersel, L. V. V., Mandigers, C. M. P. W., van de Vendel, A. J., Jeurissen, F. J. F., Nieboer, P., Deenen, M. J., van de Poel, M. H. W., Wymenga, M. N. M., van Schaik, R. H. N., van den Bosch, B. J. C., ... Cats, A. (2025). Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study. European Journal of Cancer, 224, Article 115483. https://doi.org/10.1016/j.ejca.2025.115483

Kanning, J. P., Abtahi, S., Klungel, O. H., & Ruigrok, Y. M. (2025). Author Response: Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study. Neurology, 104(12), Article e210035. https://doi.org/10.1212/WNL.0000000000210035

Hellamand, M., Moleman, T. E., Post, A. P., Mantel-Teeuwisse, A. K., Suleman, F., & Van Den Ham, H. A. (2025). Time to inclusion of selected medicines for priority diseases in National Essential Medicines Lists compared with the WHO Model List. BMJ Global Health, 10(6), Article e018550. https://doi.org/10.1136/bmjgh-2024-018550

Opalska, A., Kwa, M., & Leufkens, H. (2025). Implementation of indication restrictions made by European regulatory action for antibiotics - amoxicillin. European Journal of Pharmaceutical Sciences, 209, Article 107106. https://doi.org/10.1016/j.ejps.2025.107106

Miguel, J. W. A. M., van Veen, N. L., Jacobs, W., Damhuis, R. A. M., van Uden-Kraan, C. F., & van de Garde, E. M. W. (2025). Applied first-line systemic treatments, treatment modifications and outcomes in non-oncogenic metastatic non-small cell lung cancer in the Netherlands in 2019–2020: A nationwide study. Cancer Epidemiology, 96, Article 102809. https://doi.org/10.1016/j.canep.2025.102809

Verschueren, M. V., Hiensch, D. T. A., Plomp, P. M. J., Kastelijn, L. A., van de Garde, E. M. W., & Peters, B. J. M. (2025). Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients. Clinical Lung Cancer, 26(4), e243-e248.e1. https://doi.org/10.1016/j.cllc.2025.01.009

Lentzas, A., Their, A., Beijnen, J. H., de Gooijer, M. C., & van Tellingen, O. (2025). Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues. Biomedical Chromatography, 39(6), 1-13. Article e70099. https://doi.org/10.1002/bmc.70099

Kruijtbosch, M., Floor-Schreudering, A., van Leeuwen, E., & Bouvy, M. L. (2025). Fostering moral reflectivity in community pharmacists through moral case deliberation using the dilemma method. International Journal of Clinical Pharmacy, 47(3), 676-687. https://doi.org/10.1007/s11096-024-01854-3

Jadoenathmisier, K. D., Gardarsdottir, H., Mol, P. G. M., & Pasmooij, A. M. G. (2025). Insights from the European Medicines Agency on digital health technology derived endpoints. Drug Discovery Today, 30(6), Article 104388. https://doi.org/10.1016/j.drudis.2025.104388

Jansen-Groot Koerkamp, E. A. W., Simsek, I., Badawy, E., Heringa, M., & Bouvy, M. L. (2025). Patient counselling on opioids by pharmacy technicians: A mixed-method study to explore facilitators and barriers. PEC Innovation, 6, Article 100382. https://doi.org/10.1016/j.pecinn.2025.100382

Voogd, D. W. M., Lucassen, M. J. J., van der Noll, R., Zielhuis, S. W. J., Boss, D., Beijnen, J. H., Rosing, H., Tibben, M., Huitema, A. D. R., Schellens, J. H. M., & Steeghs, N. (2025). Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors. Oncology and Therapy, 13(2), 465-483. Article e82209. https://doi.org/10.1007/s40487-025-00340-8

Pan, X., Feng, B., Chen, Y., Wang, J., Pan, X., Lam, T., & Pan, J. (2025). Prognostic models for lung cancer in smokers and nonsmokers: an updated systematic review and meta-analysis. Oncology and Translational Medicine, 11(3), 112-117. https://doi.org/10.1097/ot9.0000000000000091

Reesink, D. J., Voskuilen, C. S., van de Garde, E. M. W., Hendricksen, K., Horenblas, S., van Melick, H. H. E., & van Rhijn, B. W. G. (2025). Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched Analysis. Clinical Genitourinary Cancer, 23(3), Article 102319. https://doi.org/10.1016/j.clgc.2025.102319

Leung, M. W. Y., Garde, E. M. W. V. D., Uitdehaag, B. M. J., Klungel, O. H., & Bazelier, M. T. (2025). The relative risk of infection in people with multiple sclerosis using disease-modifying treatment: a systematic review of observational studies. Neurological Sciences, 46(6), 2555-2569. https://doi.org/10.1007/s10072-025-08018-9

Davies, L. E. M. (2025). Pain Points: Patient Perspectives on Opioid Treatment for Chronic Pain. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2868

Vazquez-Cruz, M. E., Basurto-Lozada, P., Molina-Aguilar, C., Orozco-Ruiz, S., Van Haastrecht, B., Simonin-Wilmer, I., Martinez-Said, H., Alvarez-Cano, A., Garcia-Ortega, D. Y., Hidalgo-Miranda, A., Hinojosa-Ugarte, D., Ferreira, I., Tavares-de-la-Paz, L. A., Olguin, J. E., Salinas, I., Rodriguez-Perez, A., Martinez-Gomez, J. M., van der Zee, I., Grimes, D. R., ... Robles-Espinoza, C. D. (2025). The microenvironment of ulcerated acral melanoma is characterised by an inflammatory milieu and an enhanced humoral immune response. medRxiv. https://doi.org/10.1101/2025.05.05.25325616

Cam, H., Franzon, K., Östman, V., Kälvemark Sporrong, S., Kempen, T. G. H., Nielsen, E. I., Lindner, K.-J., Ekelo, B., Bernsten, C., Ehlin, U., Lindmark, S., Hadziosmanovic, N., & Gillespie, U. (2025). Improved Medication communication and Patient involvement At Care Transitions (IMPACT-care): study protocol for a pre-post intervention trial in older hospitalised patients. BMJ Open, 15(5), Article e099547. https://doi.org/10.1136/bmjopen-2025-099547

Meertens, M., Rosing, H., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2025). Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital-Based Towards Home-Sampling. Biomedical Chromatography, 39(5), Article e70056. https://doi.org/10.1002/bmc.70056

Jonker, A. H., Tataru, E. A., Dimmock, D. P., Bateman-House, A., Graessner, H., Baynam, G., Augustine, E. F., Jaffe, A., Pasmooij, A. M. G., Iliach, O., Horgan, R., Davies, J., Mitkus, S., Lapteva, L., Synofzik, M., Yu, T. W., O’Connor, D., & Aartsma-Rus, A. (2025). From roadmap to a sustainable end-to-end individualized therapy pathway. Therapeutic Advances in Rare Disease, 6. https://doi.org/10.1177/26330040251339204

de Haart, K., Asao, K., Ataher, Q., Geier, J., Hillen, J., Huang, K., Mol, P. G. M., Rivera, D., Wang, H., Yang, H., Zhan, S., Hoogendoorn, W. E., & Bloem, L. T. (2025). Long-term follow-up after authorization of gene therapy: leveraging real-world data. Drug Discovery Today, 30(5), Article 104337. https://doi.org/10.1016/j.drudis.2025.104337

Liang, D., Paul, A. K., Weir, D. L., Deneer, V. H. M., Greiner, R., Siebes, A., & Gardarsdottir, H. (2025). Methods in dynamic treatment regimens using observational healthcare data: A systematic review. Computer Methods and Programs in Biomedicine, 263, Article 108658. https://doi.org/10.1016/j.cmpb.2025.108658

Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(5), 719-725. https://doi.org/10.1007/s00228-025-03815-9

Beex-Oosterhuis, M. M., Lau, S. F. C., van Kesteren, C., Verloop, S., Grootens, K. P., Faber, G., Van Gool, A. R., Heerdink, E. R. R., van Marum, R. J., & Touw, D. J. (2025). The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine. Journal of Clinical Psychopharmacology, 45(3), 231-235. https://doi.org/10.1097/JCP.0000000000001979

Wang, X., Zhu, M. X., Wang, J. F., Liu, P., Zhang, L. Y., Zhou, Y., Lin, X. X., Du, Y. D., & He, K. L. (2025). Multivariable prognostic models for post-hepatectomy liver failure: An updated systematic review. World Journal of Hepatology, 17(4), Article 103330. https://doi.org/10.4254/wjh.v17.i4.103330

Overmars, L. M., van Es, B., Groepenhoff, F., De Groot, M. C. H., Somsen, G. A., Bots, S. H., Tulevski, I. I., Hofstra, L., den Ruijter, H. M., van Solinge, W. W., Hoefer, I., & Haitjema, S. (2025). Optimising coronary imaging decisions with machine learning: an external validation study. Open Heart, 12(1), Article e003072. https://doi.org/10.1136/openhrt-2024-003072

Leung, M. W. Y. (2025). Pharmacoepidemiologic studies of infection among people with multiple sclerosis: Occurrence and effects of pharmacotherapy. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2837

Postma, D. J., De Smet, P. A. G. M., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Notenboom, K. (2025). Upstream pharmaceutical supply chains of 10 high-use pharmaceuticals in the Netherlands: a cohort study. BMJ Open, 15(4), Article e099697. https://doi.org/10.1136/bmjopen-2025-099697

Westein, M. P. D. (2025). Training and Assessment in Workplace-based Community Pharmacy: Creating Foundations and Nurturing Progress. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2807

MOLecular Evaluation of Melanocytic Ambiguous Tumours (MOLEMAT) Investigators, Ebbelaar, C. F., Jansen, A. M. L., Speet, L. C. M., Schutgens, F., Zoetemeyer, S., Cleton-Jansen, A.-M., van Dijk, M. R., Breimer, G. E., Bloem, L. T., de Leng, W. W. J., van Doorn, R., Suijkerbuijk, K. P. M., Schrader, A. M. R., & Blokx, W. A. M. (2025). Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours. EBioMedicine, 114, Article 105643. https://doi.org/10.1016/j.ebiom.2025.105643

Tataru, E. A., Dooms, M., Gonzaga-Jauregui, C., Pasmooij, A. M. G., O'Connor, D. J., & Jonker, A. H. (2025). Drug–device combinations in rare diseases: Challenges and opportunities. Drug Discovery Today, 30(4), Article 104343. https://doi.org/10.1016/j.drudis.2025.104343

Essink, S. C. M., Zomerdijk, I. M., Goedecke, T., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies. Clinical Pharmacology and Therapeutics, 117(4), 1106-1114. https://doi.org/10.1002/cpt.3569

Wolthuis, D. F. G. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H. J., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Houwink, E. J. F. (2025). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas. European Journal of Human Genetics, 33(4), 413-420. https://doi.org/10.1038/s41431-024-01769-7

Emond, S. K., Goettsch, W. G., & Ollendorf, D. A. (2025). Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology and Therapeutics, 117(4), 938-945. https://doi.org/10.1002/cpt.3579

García-Sangenís, A., Lykkegaard, J., Hansen, M. P., González López-Valcárcel, B., Raynal, F., Vallejo-Torres, L., Bjerrum, L., Chalkidou, A., Jensen, J. N., Rebnord, I., Lindberg, B. H., Taxis, K., Lambert, M., Radzeviciene, R., Jaruseviciene, L., Touboul Lundgren, P., Bruno, P., Lesage, V., Kowalczyk, A., ... Llor, C. (2025). Impact of a multifaceted intervention programme on antibiotic prescribing and dispensing in four patient-centred settings in five European countries. The HAPPY PATIENT project. Family Practice, 42(2), 1-8. Article cmae064. https://doi.org/10.1093/fampra/cmae064

Krishna, R., Jonker, A. H., Morel, T., Sakushima, K., Pasmooij, A. M. G., & O'Connor, D. (2025). IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases. Nature Reviews Drug Discovery, 24(4), 233-234. https://doi.org/10.1038/d41573-024-00196-z

Ensing, H. T., Kurt, N., Janssen, R. A., Koster, E. S., & Heerdink, E. R. (2025). Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care. International Journal of Clinical Pharmacy, 47(2), 325–334. https://doi.org/10.1007/s11096-024-01829-4

Saylor, D., Rijke, N., McDonell, J., Laurson-Doube, J., Avasarala, J., Baldin, E., Banerjee, T. K., Bogdanovic, I., Bove, R., Chawla, D. K., Costello, K., Del Giovane, C., Abkari, N. E., Filippini, G., Foschi, M., Gonzalez-Lorenzo, M., Helme, A., Jacobs, D., Kalincik, T., ... Piggott, T. (2025). Recommendations for essential medicines for multiple sclerosis in low-resource settings. Multiple Sclerosis Journal, 31(4), 454-473. https://doi.org/10.1177/13524585241308134

van Loon, E., Heringa, M., Floor-Schreudering, A., de Smet, P., & Bouvy, M. (2025). Relevance of therapeutic prescription modifications in Dutch community pharmacies. The International Journal of Pharmacy Practice, 33(2), 169-179. https://doi.org/10.1093/ijpp/riae060